Abstract

Analyzing immunization coverage data is crucial to guide decision-making in national immunization programs and monitor global initiatives such as the Immunization Agenda 2030. We aimed to assess the quality of reported child immunization coverage data for 194 countries over 20 years. We analyzed child immunization coverage as reported to the World Health Organization (WHO) and the United Nations Children's Fund (UNICEF) between 2000-2019 by all WHO Member States for Bacillus Calmette-Guérin (BCG) vaccine birth dose, first and third doses of diphtheria-tetanus-pertussis-containing vaccine (DTP1, DTP3), and first dose of measles-containing vaccine (MCV1). We assessed completeness, consistency, integrity, and congruence and assigned data quality flags in case anomalies were detected. Generalized linear mixed-effects models were used to estimate the probability of flags worldwide and for different country groups over time. The probability of data quality flags was 18.2% globally (95% confidence interval [CI] 14.8-22.3). The lowest probability was seen in South-East Asia (6.3%, 3.3-11.8, p = 0.002), the highest in the Americas (29.7%, 22.7-37.9, p < 0.001). The probability of data quality flags declined by 5.1% per year globally (3.2-7.0, p < 0.001). The steepest decline was seen in Africa (-9.6%, -13.0 to -5.8, p < 0.001), followed by Europe (-5.4%, -9.2 to -1.6, p = 0.0055), and the Americas (-4.9%, -9.2 to -0.6, p = 0.026). Most country groups showed a statistically significant decline, and none had a statistically significant increase. Over the past two decades, the quality of global immunization coverage data appears to have improved. However, progress has not been universal. The results highlight the need for joint efforts so that all countries collect, report, and use high-quality data for action in immunization.

Highlights

  • High-quality data are key in public health and development programs [1,2,3]

  • Performance is often measured in terms of immunization coverage, that is the proportion of vaccinated individuals in the target population for a specific vaccine dose

  • To account for the heterogeneous landscape of immunization systems among countries, we summarized country-provided information on each vaccine dose for every year as one country-year-vaccine coverage report

Read more

Summary

Introduction

High-quality data are key in public health and development programs [1,2,3]. The COVID-19 pandemic has illustrated that well-functioning health information systems and high-quality data are crucial to prevention, provision of care, and the successful rollout of new vaccines [10]. Data are needed to guide decision-making and monitor performance at the local, regional, and global level. Since the inception of the World Health Organization’s (WHO) Expanded Programme on Immunization (EPI) in 1974 and the adoption of the Global Vaccine Action Plan (GVAP) in 2012, estimated coverage rates have increased worldwide but plateaued around 85% between 2010 and 2019 [11,12,13,14]. The Vaccine Alliance, cited data quality problems in 2020 as a “very high risk” to their investments [21]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call